Şeyda Atadan Memiş: My name is Şeyda Atadan Memiş. I am the general manager for UK and Ireland in Takeda. Dr Suki Balendra: Hi, I'm Suki Balendra, I'm Director of Strategic Partnerships for Paddington Life Sciences Dr Sue Windham-Bannister: I'm Sue Windham-Bannister and I currently serve as the CEO of an LLC Biomedical Growth Strategies. Dr Suki Balendra: Paddington Life Sciences sits in Northwest London and at the heart of Paddington Life Sciences. It is about this community that we serve, about making the research more inclusive, finding new innovations that really help our communities. But Paddington has allowed us to work very collaboratively with our patients. Rather than all our institutions working in silo. Paddington has brought everyone together with the common aim of serving our patients. Şeyda Atadan Memiş: So for us, Paddington Life Sciences Partnership is a shining example of how academia, NHS, HCPs, industry players, technology companies and other organisations come together around the united purpose of improving the health outcomes of patients in the communities that we serve. I think all of the problems we face in the healthcare environment ecosystem today can actually be addressed at smaller scales by local clusters and such partnerships like Paddington Life Sciences. Dr Sue Windham-Bannister: What you're really talking about is a hallmark of an innovation ecosystem. Those partnerships and those collaborations, which is where members of the community, be they academic, be they industry, large companies and small companies are really working together. These partnerships, these collaborative areas, these ecosystems really punch above their weight class in terms of being sources of a lot of the innovation that we're seeing. I think that one of the most important lessons, Suki, should be that that all clusters or ecosystems should take away is where you started your comments, which is the patient is at the centre always. It's why any of us in the life sciences get up every day. It's because of the patient and what we can deliver to patients. Dr Suki Balendra: For me, partnership and collaborative working is the way that we should all be working in the NHS. So it's very exciting for me in my role within Paddington Life Sciences that I have the opportunity to work with all these different sectors on a daily basis. And take that learning back to our organisation about how we can approach different challenges, different problems within the NHS. I'm really excited when I look around the UK actually, that the models that we have created in London, in Cambridge and Oxford are being replicated across the country. Şeyda Atadan Memiş: I think it's a bright example of how such a collaboration impacts the local community first, but broadly it also benefits the government ambitions as stated in the Life Sciences Sector Plan and also it helps to serve the UK's reputation and position as a global life sciences player.